Related Experiment Video

Updated: Jul 15, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy

Rami Ben-Yosef1, Alex Starr, Victoria Karaush

  • 1Department of Oncology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel. ramiby@post.tau.ac.il

The Prostate
|April 19, 2007
PubMed
Abstract

Insights

High ErbB-4 expression in prostate cancer cells drives proliferation and migration. An anti-ErbB-4 monoclonal antibody (Mab) effectively inhibited cancer cell growth and tumor development in vivo.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer (PC) remains a significant health concern, necessitating novel therapeutic targets.
  • ErbB-4, a receptor tyrosine kinase, has been implicated in various cancers, but its role in advanced PC requires further elucidation.

Purpose of the Study:

  • To investigate ErbB-4 expression in advanced human prostate cancer cell lines.
  • To determine the role of ErbB-4 in PC cell motility, migration, and tumorigenic potential.
  • To evaluate the efficacy of an anti-ErbB-4 monoclonal antibody (Mab) against PC cells in vitro and in vivo.

Main Methods:

  • ErbB-4 expression was assessed in PC-3, Cl-1, and Du-145 cell lines.
  • Cl-1 sub-clones with varying ErbB-4 levels were generated and analyzed for proliferation, migration, and survival after Mab treatment.
  • Tumorigenicity and Mab efficacy were evaluated in vivo using subcutaneous tumors in nude mice.

Main Results:

  • All studied PC cell lines expressed ErbB-4, with PC-3 and Du-145 showing high levels and Cl-1 exhibiting heterogeneity.
  • Cl-1 sub-clones with high ErbB-4 expression demonstrated increased motility, migration, and proliferation in vitro, and enhanced tumor growth in vivo.
  • Mab treatment inhibited the proliferation of high-ErbB-4 expressing cells in vitro and reduced tumor growth in vivo.

Conclusions:

  • High ErbB-4 expression in prostate cancer cells correlates with increased proliferative, migratory, and tumorigenic potential.
  • The anti-ErbB-4 Mab demonstrated significant inhibitory effects on PC cell proliferation and tumor growth.
  • ErbB-4 represents a promising therapeutic target for advanced prostate cancer treatment.

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...